Multifarious Cataract cures emerge
Bio Spectrum|August 2021
Being documented as India’s most significant cause of bilateral blindness that is for both eyes, cataract has become an economic and social burden that is increasing with the ageing population.
Dr Manbeena Chawla

In fact, by age 80, most people have or have had cataract, either in one eye or both. In addition to aging, cataract formation is caused by other risk factors, such as smoking, diabetes, and UV light damage.

A cataract begins when proteins in the eye form clumps that prevent the lens from sending clear images to the retina. The retina works by converting the light that comes through the lens into signals. It sends the signals to the optic nerve, which carries them to the brain. It develops slowly and eventually interferes with your vision with a cloudy appearance.

Continue reading your story on the app

Continue reading your story in the magazine

MORE STORIES FROM BIO SPECTRUMView All

“R&D outsourcing has become a ‘must have' than ‘good-to have' strategy”

Aragen Life Sciences (formerly GVK BIO), a leading contract research and development organisation headquartered in Hyderabad, is marking its transition to a new brand identity in its 20th year. Established in 2001, the company is poised for growth in the outsourced discovery, development, and manufacturing services sector across both large and small molecule platforms with new investments and collaborations. In conversation with BioSpectrum, Manni Kantipudi, Chief Executive Officer, Aragen Life Sciences, Hyderabad reveals more about the company’s recent rebranding and growth plans. Edited excerpts;

4 mins read
Bio Spectrum
September 2021

Premas Biotech to commercialise VLP vaccine tech against Delta variant

Gurugram-based Premas Biotech has signed a licensing deal with Oravax Medical for the development and commercialisation of its virus-like-particle COVID-19 vaccine technology.

1 min read
Bio Spectrum
September 2021

SARS-CoV-2: A Biochemical Treatise on its Past, Present & Future

The SARS-CoV-2 pandemic is unprecedented but equally unprecedented is the contribution of scientists who have helped us in understanding the mechanisms by which it infects human beings and also, developing a variety of vaccines to protect the masses, in a year’s time, which can be called truly groundbreaking. This article gives an overview of the progress made by scientists around the world working round the clock in developing an understanding of the SARS-CoV-2 evolution and COVID-19 disease pathogenesis, and also makes an attempt to suggest the possible ways of coping with this pandemic if we have to co-exist with it forever!

4 mins read
Bio Spectrum
September 2021

Merck launches Pergoveris Pen for fertility treatment in India

Merck Specialties, the healthcare business of Merck in India, has launched Pergoveris Pen for advanced infertility treatment in India.

1 min read
Bio Spectrum
September 2021

How tech innovations impact cardiac care

Cardiac care has seen a transformation over the years with technology playing an important role. Armed with Artificial intelligence (AI) and machine learning (ML), cardiac care providers, with the right technology, have received the right impetus to revolutionise treatment mechanisms. Let us delve into the new technologies which the industry is offering to mankind and decipher the way forward.

6 mins read
Bio Spectrum
September 2021

GUNG-HO PHARMA R&D INVESTMENTS SURPASS $3B

While the pharmaceutical industry helped combat COVID-19, from R&D actions on potential treatment strategies to balancing the medicines supply chain in the time of crisis, it struggled to maintain the natural market flow. As a result, many pharma companies had to abort some of their ongoing R&D investment plans. However for FY20-21, the average R&D expenses constituted 7.2 per cent of the total revenues of the pharma companies, with Lupin, Alembic Pharma and Dr. Reddy’s spending more than others. The cumulative R&D expenditure of the leading 10 pharma companies has been around Rs 10,627 crore ($1.43 billion) in the previous fiscal. This figure eventually reaches an approximate amount of Rs 22,500 crore ($3.03 billion) after considering the cumulative expenditure by other small and medium players of the India pharma industry.

10+ mins read
Bio Spectrum
September 2021

Glenmark ties up with SaNOtize to commercialise COVID-19 nasal spray

Mumbai-based Glenmark Pharmaceuticals and Canadian biotech firm SaNOtize Research & Development Corporation

1 min read
Bio Spectrum
September 2021

CEPI prioritises Rift Valley fever vax

Sep 01, Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) has signed an implementing partner agreement with Integrum Scientific (US) as part of its ongoing efforts to combat Rift Valley fever (RVF)—one of its priority diseases with epidemic potential.

1 min read
Bio Spectrum
September 2021

3D printing moulds healthcare innovations

Pharmaceuticals, bio-medicine, aviation, and automobiles industries have rapidly adopted 3D printing over the years, worldwide, to develop new solutions and prototypes. It is also helping many industries, healthcare, in particular, increase productivity. Despite all its advantages, 3D printing technology is currently posing a number of challenges in the market such as initial costs, limitation to the metals and plastics used for 3D printing, lack of policy standardisation, etc.

7 mins read
Bio Spectrum
September 2021

Mynvax Offers ‘Warm Vaccine' For COVID-19

Biotech startup Mynvax, incubated at the Indian Institute of Science (IISc) in Bengaluru, has developed heat-tolerant COVID-19 vaccine formulations.

1 min read
Bio Spectrum
September 2021
RELATED STORIES

Building Community Through Education

KIRAN BIR SETHI is changing the experience of childhood in Indian cities through her education curriculum and initiatives to build healthy relationships between students and their communities. Here she is interviewed by KASHISH KALWANI.

10+ mins read
Heartfulness eMagazine
September 2021

POKÉMONSTER HUNTER

MONSTER HUNTER STORIES 2: WINGS OF RUIN is an approachable spin-off.

3 mins read
PC Gamer US Edition
November 2021

Granny Chic Galore!

A homeowner’s holiday décor is an homage to Christmas at her grandma’s house.

5 mins read
Cottages and Bungalows
FMD Christmas 21

FACEBOOK SLAMS UK ANTITRUST WATCHDOG OVER CALL TO SELL GIPHY

Facebook has criticized the U.K. competition watchdog’s provisional decision ordering that it sell offGiphy because it said the acquisition of the company stifles competition for animated images.

1 min read
Techlife News
Techlife News #515

Tuning In to a Happier City

Noise is an irritant of urban life. But there are ways to make it easier on the ears—and the psyche

10+ mins read
Bloomberg Businessweek
September 06, 2021

NATURAL FOOD: Sources Of Retinol

Retinol considered the queen in skin care as it increases collagen production, which is a very important aspect in delaying skin aging.

1 min read
Women Fitness
September 2021

TIKTOK TO LET USERS SHOP THROUGH APP WITH SHOPIFY DEAL

TikTok users will soon be able to buy stuff directly through the short videos on the app — something they had only been able to do through ads until now.

1 min read
AppleMagazine
August 27, 2021

Revival of the Fittest

ORIGIN EFFECTS RD COMPACT HOT ROD

4 mins read
Guitar World
October 2021

Get to Know The Hangry Woman

Mila Buckley, the author behind acclaimed diabetes blog hangrywoman.com, was initially diagnosed with type 2 diabetes. Only when treatments were found to not be working was she accurately diagnosed with a rarer disorder: latent autoimmune diabetes in adults (LADA). Her journey hasn’t been an easy one. That’s why she’s made it her purpose to shed light, share tips and bring hope and community to her readership.

4 mins read
Clean Eating
Fall 2021

INDIANA NOTIFYING 750K AFTER COVID-19 TRACING DATA ACCESSED

Indiana health officials said they are notifying nearly 750,000 state residents that a cybersecurity company “improperly accessed” their personal data from the state’s online COVID-19 contact tracing survey — a description the company disputed as a “falsehood.”

2 mins read
Techlife News
Techlife News #512